QuantumScape has started producing low volumes of its first B-sample cells (QSE-5) and shipping them for automotive customer testing, achieving a key 2024 goal. They have also signed an agreement with PowerCo to bring QSE-5 technology into mass production. The company anticipates Cobra heat treatment equipment will be in place by the end of 2024.
Started producing low volumes of first B-sample cells and shipping them for automative customer testing.
Signed agreement with PowerCo for mass production of QSE-5 technology.
Raptor is now part of baseline production process.
Anticipate Cobra heat treatment equipment will be in place by the end of 2024.
QuantumScape has tightened its full-year forecast for Adjusted EBITDA loss to be between $280M and $300M. They are lowering their 2024 forecast for capital expenditures to be between $60M and $75M.